Morningside Venture Investments Ltd - Jan 6, 2022 Form 3/A - Amendment Insider Report for Amylyx Pharmaceuticals, Inc. (AMLX)

Role
10%+ Owner
Signature
/s/ Frances Anne Elizabeth Richard, for Morningside Venture Investments Limited
Stock symbol
AMLX
Transactions as of
Jan 6, 2022
Transactions value $
$0
Form type
3/A - Amendment
Date filed
3/17/2022, 05:14 PM
Date Of Original Report
Jan 25, 2022
Previous filing
Nov 18, 2021
Next filing
Mar 17, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding AMLX Series A Preferred Stock Jan 6, 2022 Common Stock 1.41M See Explanation of Responses F1, F2
holding AMLX Series B Preferred Stock Jan 6, 2022 Common Stock 6.41M See Explanation of Responses F1, F2
holding AMLX Series C-1 Preferred Stock Jan 6, 2022 Common Stock 974K See Explanation of Responses F1, F2
holding AMLX Series C-2 Preferred Stock Jan 6, 2022 Common Stock 1.62M See Explanation of Responses F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share of Series A, Series B, Series C-1 and Series C-2 preferred stock (collectively the "Preferred Stock") is convertible on a one-for-one basis into Common Stock at any time at the election of the Reporting Person and will automatically convert upon the closing of the Issuer's initial public offering into the number of shares of the Issuer's Common Stock shown in column 3 without payment or further consideration. The Preferred Stock has no expiration date.
F2 Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho are the directors of Morningside Venture Investments Limited ("Morningside") and share voting and dispositive power with respect to the securities held by Morningside and MVIL, LLC ("MVIL LLC"), Morningside's wholly-owned subsidiary. Cheng Yee Wing Betty and Wong See Wai are the managers of MVIL LLC and share voting and dispositive power with respect to the securities held by MVIL LLC. Ms. Cheng and Mr. Wong each disclaim ownership of the securities owned by MVIL LLC.
F3 The shares of Series C-2 preferred stock are held by MVIL LLC.

Remarks:

The Reporting Persons are jointly filing this Form 3 pursuant to Rule 16a-3(j) under the Exchange Act.